Source: Eur Respir J 2005; 25: 634-639
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Huiart L., Ernst P., Ranouil X., Suissa S.. Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. Eur Respir J 2005; 25: 634-639

Member's Comments

No comment yet.

Related content which might interest you: Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD Source: Eur Respir J 2010; 35: 1003-1021 Year: 2010 Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD Source: Eur Respir J 2007; 29: 1115-1119 Year: 2007 Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD Source: Eur Respir J 2012; 39: 1097-1103 Year: 2012 Inhaled corticosteroids and the risk of a first exacerbation in COPD patients Source: Eur Respir J 2004; 23: 692-697 Year: 2004 Risk of myocardial infarction (MI) associated with acute exacerbations of COPD (AECOPD): Effects of exacerbation frequency Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 795-798 Year: 2003 Effect of basic therapy of chronic obstructive pulmonary disease on the clinical course of acute myocardial infarction Source: International Congress 2014 – Comorbidities Year: 2014 Statin use is associated with reduced mortality in COPD Source: Eur Respir J 2007; 29: 279-283 Year: 2007 Effect of severity of exacerbations of COPD and hospitalised pneumonia on risk of myocardial infarction Source: International Congress 2017 – COPD: risk factors and prognosis Year: 2017 Prolonging the interval to the next acute exacerbations Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005 Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter? Source: Eur Respir J 2003; 21: 260-266 Year: 2003 Inhaled corticosteroids and hospitalisation due to exacerbation of COPD Source: Eur Respir J 2003; 22: 286-289 Year: 2003 Severity assessment in acute exacerbations of COPD Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005 Inhaled maintenance therapy and risk of first or subsequent emergency department visit/hospitalization in patients with COPD Source: Annual Congress 2006 - COPD therapy Year: 2006 Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007 Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia Source: Eur Respir J 2010; 36: 751-757 Year: 2010 Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids Source: Annual Congress 2006 - COPD therapy Year: 2006 The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005